EQS-News

VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe 11.04.2026, 16:40 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Varon oxygen concentrator / Key word(s): Miscellaneous
VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe

11.04.2026 / 16:40 CET/CEST
The issuer is solely responsible for the content of this announcement.


LONDON, April 11, 2026 /PRNewswire/ -- Respiratory diseases continue to place increasing pressure on healthcare systems across Germany, the United Kingdom, and France. VARON oxygen concentrator supports this growing need by providing modern respiratory care solutions for patients requiring reliable oxygen therapy at home and on the move.

Rising cases of COPD, chronic lung conditions, and post-viral breathing difficulties are driving stronger demand for oxygen therapy that can support both home care and daily mobility.

Growing Need for Modern Oxygen Therapy in Europe

Many patients requiring long-term respiratory support depend on oxygen therapy to maintain stable oxygen levels. Traditionally, treatment has relied on oxygen cylinders or stationary systems, which can limit movement and independence.

Today, healthcare providers and patients are increasingly shifting toward the oxygen machine category of devices that deliver medical oxygen in a more flexible and user-friendly way. This shift supports Europe's broader movement toward home-based care and patient independence.

How a Portable Oxygen Concentrator Works

A portable oxygen concentrator is a respiratory device that draws in surrounding air, removes nitrogen, and delivers concentrated oxygen to the user. This process allows patients to receive continuous oxygen support without relying on heavy tanks or frequent refills.

These devices are increasingly used by patients managing chronic respiratory conditions who require oxygen support throughout the day.

VARON Portable Oxygen Concentrator VP-2

The VARON VP-2 portable oxygen concentrator is designed to meet these growing healthcare needs with a focus on mobility and stability.

Key features include:

  • Adjustable pulse flow (1–5L settings)
  • Oxygen concentration of 93% ± 3%
  • Breath-controlled and fixed-frequency oxygen delivery modes
  • Lightweight design at 2.2 kg (4.85 lb)
  • Backpack-style carrying system for flexible use

Extended battery options further support longer usage times, making the device suitable for short trips, daily activities, and extended periods away from home.

Europe's Shift Toward Portable Respiratory Solutions

Across Europe, healthcare systems are increasingly focusing on portable and home-based respiratory care. Patient preference for independence, comfort, and improved quality of life drives this trend.

As demand grows, the portable oxygen concentrator category is becoming an essential part of modern respiratory treatment, offering a practical alternative to traditional oxygen systems.

With a focus on portability, reliability, and ease of use, VARON continues to innovate oxygen therapy technology for users across Europe.

Media Contact:
VARON Oxygen Concentrators
Email: support@varoninc.uk 

Cision View original content:https://www.prnewswire.co.uk/news-releases/varon-delivers-advanced-portable-oxygen-concentrator-to-meet-rising-demand-in-europe-302739760.html

rt.gif?NewsItemId=EN31524&Transmission_Id=202604111034PR_NEWS_EURO_ND__EN31524&DateId=20260411


11.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2306748  11.04.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer